When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...

RSV leads to over 100,000 infant deaths annually, but WHO’s latest guidance recommends maternal vaccines and monoclonal ...

Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

Respiratory syncytial virus (RSV) causes millions of childhood illnesses yearly, particularly in poorer countries. On 30 May 2025, the World Health Organisation issued its first global guidance ...

The Centers for Disease Control and Prevention (CDC) will no longer recommend that “healthy” children and pregnant women receive the COVID-19 vaccine, Health and Human Services (HHS) Secretary ...

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...

Maternal vaccination and, to a lesser extent, nirsevimab appear to significantly reduce RSV-related hospitalizations in infants.

RSV causes about 100,000 deaths and more than 3.6 million hospitalisations in children under the age of 5 worldwide ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...